Skip to main content

Table 2 Survival according to the lepidic component and type

From: The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung

 

N

1 yr. (95 % CI)

2 yr. (95 % CI)

5 yr. (95 % CI)

10 yr. (95 % CI)

Total

101

84.2 (77.3-91.6)

76.2 (68.3-85.0)

58.1 (49.2-68.6)

34.1 (25.9-44.8)

Lepidic component

     

<50 %

44

84.1 (73.9-95.6)

72.6 (60.5-87.1)

56.2 (43.2-73.1)

32.8 (21.4-50.3)

50-79 %

26

80.8 (67.0-97.4)

72.6 (60.5-87.1)

56.2 (43.2-73.1)

32.8 (21.4-50.3)

80-95 %

24

87.5 (75.2-100)

87.5 (75.2-100)

66.7 (50.2-88.5)

37.5 (22.4-62.9)

96-100 %

6

83.3 (58.3-100)

83.3 (58.3-100)

66.7 (37.9-100)

50.0 (22.5-100)

Unknown

1

    

Lepidic type

     

Mucinous

16

75.0 (56.5-99.5)

62.5 (42.8-91.4)

31.2 (15.1-64.6)

12.5 (3.4-45.7)

Non-mucinous

71

88.7 (81.7-96.4)

81.7 (73.2-91.2)

69.0 (59.1-80.7)

43.7 (33.5-56.9)

Mucinous and non-mucinous

14

71.4 (51.3-99.5)

63.5 (42.4-95.1)

31.8 (14.2-70.8)

7.9 (1.2-51.9)

  1. Yr. - Year, CI - Confidence interval